These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 25980764

  • 1. EDIL3 is a novel regulator of epithelial-mesenchymal transition controlling early recurrence of hepatocellular carcinoma.
    Xia H, Chen J, Shi M, Gao H, Sekar K, Seshachalam VP, Ooi LL, Hui KM.
    J Hepatol; 2015 Oct; 63(4):863-73. PubMed ID: 25980764
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H, Ooi LL, Hui KM.
    Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
    [Abstract] [Full Text] [Related]

  • 3. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
    Shi Y, Qin N, Zhou Q, Chen Y, Huang S, Chen B, Shen G, Jia H.
    J Transl Med; 2017 Aug 15; 15(1):176. PubMed ID: 28810875
    [Abstract] [Full Text] [Related]

  • 4. Activation of phosphatidylinositol 3-kinase/Akt signaling mediates sorafenib-induced invasion and metastasis in hepatocellular carcinoma.
    Wang H, Xu L, Zhu X, Wang P, Chi H, Meng Z.
    Oncol Rep; 2014 Oct 15; 32(4):1465-72. PubMed ID: 25070581
    [Abstract] [Full Text] [Related]

  • 5. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
    Chen L, Guo P, He Y, Chen Z, Chen L, Luo Y, Qi L, Liu Y, Wu Q, Cui Y, Fang F, Zhang X, Song T, Guo H.
    Cell Death Dis; 2018 May 01; 9(5):513. PubMed ID: 29725020
    [Abstract] [Full Text] [Related]

  • 6. MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence.
    Liu M, Hu Q, Tu M, Wang X, Yang Z, Yang G, Luo R.
    J Exp Clin Cancer Res; 2018 Jan 22; 37(1):10. PubMed ID: 29357919
    [Abstract] [Full Text] [Related]

  • 7. SIN1 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition.
    Xu J, Li X, Yang H, Chang R, Kong C, Yang L.
    Cancer; 2013 Jun 15; 119(12):2247-57. PubMed ID: 23564492
    [Abstract] [Full Text] [Related]

  • 8. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.
    Yan H, Dong X, Zhong X, Ye J, Zhou Y, Yang X, Shen J, Zhang J.
    Mol Carcinog; 2014 Dec 15; 53(12):960-9. PubMed ID: 23861222
    [Abstract] [Full Text] [Related]

  • 9. Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition.
    Xiao S, Chang RM, Yang MY, Lei X, Liu X, Gao WB, Xiao JL, Yang LY.
    Hepatology; 2016 Apr 15; 63(4):1256-71. PubMed ID: 26698646
    [Abstract] [Full Text] [Related]

  • 10. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Ding ZY, Jin GN, Wang W, Chen WX, Wu YH, Ai X, Chen L, Zhang WG, Liang HF, Laurence A, Zhang MZ, Datta PK, Zhang B, Chen XP.
    Hepatology; 2014 Nov 15; 60(5):1620-36. PubMed ID: 24954480
    [Abstract] [Full Text] [Related]

  • 11. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang C, Guo F, Xu G, Ma J, Shao F.
    Oncol Rep; 2015 Apr 15; 33(4):1872-82. PubMed ID: 25653024
    [Abstract] [Full Text] [Related]

  • 12. A double-negative feedback loop between Wnt-β-catenin signaling and HNF4α regulates epithelial-mesenchymal transition in hepatocellular carcinoma.
    Yang M, Li SN, Anjum KM, Gui LX, Zhu SS, Liu J, Chen JK, Liu QF, Ye GD, Wang WJ, Wu JF, Cai WY, Sun GB, Liu YJ, Liu RF, Zhang ZM, Li BA.
    J Cell Sci; 2013 Dec 15; 126(Pt 24):5692-703. PubMed ID: 24101726
    [Abstract] [Full Text] [Related]

  • 13. Tim-3 fosters HCC development by enhancing TGF-β-mediated alternative activation of macrophages.
    Yan W, Liu X, Ma H, Zhang H, Song X, Gao L, Liang X, Ma C.
    Gut; 2015 Oct 15; 64(10):1593-604. PubMed ID: 25608525
    [Abstract] [Full Text] [Related]

  • 14. AZGP1 suppresses epithelial-to-mesenchymal transition and hepatic carcinogenesis by blocking TGFβ1-ERK2 pathways.
    Xu MY, Chen R, Yu JX, Liu T, Qu Y, Lu LG.
    Cancer Lett; 2016 May 01; 374(2):241-9. PubMed ID: 26902423
    [Abstract] [Full Text] [Related]

  • 15. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Feng XJ, Pan Q, Wang SM, Pan YC, Wang Q, Zhang HH, Zhu MH, Zhang SH.
    Tumour Biol; 2016 Aug 01; 37(8):11457-67. PubMed ID: 27010469
    [Abstract] [Full Text] [Related]

  • 16. Salt-inducible Kinase (SIK1) regulates HCC progression and WNT/β-catenin activation.
    Qu C, He D, Lu X, Dong L, Zhu Y, Zhao Q, Jiang X, Chang P, Jiang X, Wang L, Zhang Y, Bi L, He J, Peng Y, Su J, Zhang H, Huang H, Li Y, Zhou S, Qu Y, Zhao Y, Zhang Z.
    J Hepatol; 2016 May 01; 64(5):1076-1089. PubMed ID: 26778753
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.
    Chen WX, Zhang ZG, Ding ZY, Liang HF, Song J, Tan XL, Wu JJ, Li GZ, Zeng Z, Zhang BX, Chen XP.
    Oncotarget; 2016 Apr 19; 7(16):22674-86. PubMed ID: 26993767
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
    Zhou JN, Zeng Q, Wang HY, Zhang B, Li ST, Nan X, Cao N, Fu CJ, Yan XL, Jia YL, Wang JX, Zhao AH, Li ZW, Li YH, Xie XY, Zhang XM, Dong Y, Xu YC, He LJ, Yue W, Pei XT.
    Hepatology; 2015 Sep 19; 62(3):801-15. PubMed ID: 25953743
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
    Xia L, Huang W, Tian D, Zhu H, Qi X, Chen Z, Zhang Y, Hu H, Fan D, Nie Y, Wu K.
    Hepatology; 2013 Feb 19; 57(2):610-24. PubMed ID: 22911555
    [Abstract] [Full Text] [Related]

  • 20. Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway.
    Wu Y, Liu H, Weng H, Zhang X, Li P, Fan CL, Li B, Dong PL, Li L, Dooley S, Ding HG.
    Int J Oncol; 2015 Mar 19; 46(3):1275-85. PubMed ID: 25572615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.